215 related articles for article (PubMed ID: 32724383)
1. Fat mass and obesity-associated protein promotes the tumorigenesis and development of liver cancer.
Ye Z; Wang S; Chen W; Zhang X; Chen J; Jiang J; Wang M; Zhang L; Xuan Z
Oncol Lett; 2020 Aug; 20(2):1409-1417. PubMed ID: 32724383
[TBL] [Abstract][Full Text] [Related]
2. N
Wang D; Qu X; Lu W; Wang Y; Jin Y; Hou K; Yang B; Li C; Qi J; Xiao J; Che X; Liu Y
Front Oncol; 2021; 11():681280. PubMed ID: 34277426
[TBL] [Abstract][Full Text] [Related]
3. m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation.
Li J; Zhu L; Shi Y; Liu J; Lin L; Chen X
Am J Transl Res; 2019; 11(9):6084-6092. PubMed ID: 31632576
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability.
Zou L; Chen W; Zhou X; Yang T; Luo J; Long Z; Wu J; Lv D; Mao X; Cen S
Cell Death Discov; 2022 Apr; 8(1):184. PubMed ID: 35397614
[TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer.
Lai Y; Dong H; Xu P; Wang J; Feng W; Zhao Z; Sha L
BMC Gastroenterol; 2024 Jan; 24(1):29. PubMed ID: 38200441
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
7. The RNA N6-Methyladenosine Demethylase FTO Promotes Head and Neck Squamous Cell Carcinoma Proliferation and Migration by Increasing CTNNB1.
Zhang Y; Chen L; Wu X; Sun Z; Wang F; Wang B; Dong P
Int J Gen Med; 2021; 14():8785-8795. PubMed ID: 34853532
[TBL] [Abstract][Full Text] [Related]
8. FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.
Sun Z; Sun X; Qin G; Li Y; Zhou G; Jiang X
Epigenetics; 2023 Dec; 18(1):2242688. PubMed ID: 37538000
[TBL] [Abstract][Full Text] [Related]
9. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
Azzam SK; Alsafar H; Sajini AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
[TBL] [Abstract][Full Text] [Related]
10. The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers.
Wang JY; Chen LJ; Qiang P
Onco Targets Ther; 2020; 13():12845-12856. PubMed ID: 33364780
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of FTO inhibits excessive proliferation and promotes the apoptosis of human glomerular mesangial cells by alleviating FOXO6 m6A modification via YTHDF3-dependent mechanisms.
Zhuang X; Liu T; Wei L; Gao J
Front Pharmacol; 2023; 14():1260300. PubMed ID: 37822879
[No Abstract] [Full Text] [Related]
12. The m6A demethylase FTO promotes keloid formation by up-regulating COL1A1.
Ren S; Ji Y; Wang M; Ye M; Huang L; Cai X
Ann Transl Med; 2023 Jan; 11(1):15. PubMed ID: 36760238
[TBL] [Abstract][Full Text] [Related]
13. The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer.
Zhao Y; Hu X; Yu H; Sun H; Zhang L; Shao C
Research (Wash D C); 2024; 7():0313. PubMed ID: 38384328
[TBL] [Abstract][Full Text] [Related]
14. Roles of N6-Methyladenosine Demethylase FTO in Malignant Tumors Progression.
Zheng QK; Ma C; Ullah I; Hu K; Ma RJ; Zhang N; Sun ZG
Onco Targets Ther; 2021; 14():4837-4846. PubMed ID: 34556998
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Fat Mass and Obesity Associated (FTO) Promotes the Progression of Intrahepatic Cholangiocarcinoma.
Rong ZX; Li Z; He JJ; Liu LY; Ren XX; Gao J; Mu Y; Guan YD; Duan YM; Zhang XP; Zhang DX; Li N; Deng YZ; Sun LQ
Front Oncol; 2019; 9():369. PubMed ID: 31143705
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine demethylase fat mass and obesity-associated protein suppresses hyperglycemia-induced endothelial cell injury by inhibiting reactive oxygen species formation via autophagy promotion.
Xie D; Yang K; Xu Y; Li Y; Liu C; Dong Y; Chi J; Yin X
J Diabetes Complications; 2024 Jun; 38(8):108801. PubMed ID: 38935979
[TBL] [Abstract][Full Text] [Related]
17. m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer.
Duan X; Yang L; Wang L; Liu Q; Zhang K; Liu S; Liu C; Gao Q; Li L; Qin G; Zhang Y
Cell Biosci; 2022 May; 12(1):60. PubMed ID: 35568876
[TBL] [Abstract][Full Text] [Related]
18. Novel positioning from obesity to cancer: FTO, an m
Chen J; Du B
J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
[TBL] [Abstract][Full Text] [Related]
19. Increased m6A modification of RNA methylation related to the inhibition of demethylase FTO contributes to MEHP-induced Leydig cell injury
Zhao T; Wang J; Wu Y; Han L; Chen J; Wei Y; Shen L; Long C; Wu S; Wei G
Environ Pollut; 2021 Jan; 268(Pt A):115627. PubMed ID: 33010548
[TBL] [Abstract][Full Text] [Related]
20. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
[No Abstract] [Full Text] [Related]
[Next] [New Search]
